Farallon Capital Partners, L.P. 13D and 13G filings for Perspective Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-05 2:59 pm Purchase | 2025-12-31 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Partners, L.P. | 5,427,479 8.200% | 1,950,252 (+56.09%) | Filing |
| 2025-11-12 12:22 pm Sale | 2025-09-30 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Partners, L.P. | 3,477,227 5.100% | -2,546,000 (-42.27%) | Filing |
| 2025-05-08 4:09 pm Purchase | 2025-03-31 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Partners, L.P. | 6,023,227 8.800% | 707,000 (+13.30%) | Filing |
| 2025-02-05 1:10 pm Purchase | 2024-12-31 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Partners, L.P. | 5,316,227 7.600% | 252,000 (+4.98%) | Filing |
| 2024-11-14 8:21 pm Purchase | 2024-11-08 | 13G | PERSPECTIVE THERAPEUTICS, INC. CATX | Farallon Capital Partners, L.P. | 5,064,227 7.300% | 5,064,227 (New Position) | Filing |